The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

In Episode 67 of The Digital Health Podcast, Lucas and Luna explore how artificial intelligence is analyzing vocal biomarkers to screen for depression and mental health conditions. They focus on the work of companies like Kintsugi and Sonde Health, which use voice recordings to detect subtle changes in pitch, tone, and rhythm that correlate with depression. Lucas explains the science behind vocal biomarkers—how depression affects the muscles that control the vocal cords, leading to flattened prosody. Luna raises privacy concerns about voice data being recorded without consent, and they discuss ethical frameworks being developed. The hosts also connect this to the broader trend of passive mental health monitoring, where apps can detect depression from your phone microphone without you speaking at all. A concrete, forward-looking conversation about the promise and peril of AI listening for mental health.

#DigitalHealth #MentalHealth #AI #VoiceAI #DepressionDetection #VocalBiomarkers #Kintsugi #SondeHealth #HealthTech #Business #Technology #MachineLearning #Privacy #Ethics #PassiveMonitoring #HealthcareInnovation #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

A single selfie could flag a rare genetic condition years before symptoms appear. Lucas and Luna explore how computer vision models are being trained to detect subtle facial markers of diseases like DiGeorge syndrome and Noonan syndrome. They look at the work of companies like FDNA and its Face2Gene platform, which has analyzed over 500,000 facial images to help clinicians narrow down diagnoses. They discuss the accuracy rates — around 90 percent for certain syndromes — and the ethical questions around consent, bias, and false positives. The conversation also touches on how these tools are being integrated into pediatric workflows and the potential for smartphone-based screening in underserved areas. A fascinating look at how AI is giving doctors a new diagnostic sense.

#RareDisease #AI #ComputerVision #FacialRecognition #HealthTech #Genetics #FDNATechnology #Face2Gene #Pediatrics #Diagnostics #DigitalHealth #MachineLearning #HealthcareAI #Business #Technology #FexingoBusiness #BusinessPodcast #TheDigitalHealthPodcast

Keep every episode free: buymeacoffee.com/fexingo

Clinical trial enrollment is notoriously slow — 80 percent of trials fail to meet enrollment targets on time, and patients often wait months to find out if they qualify. In this episode, Lucas and Luna look at how AI-powered matching platforms are compressing that timeline from months to days. They examine the case of Triall, a startup using natural language processing to scan electronic health records against trial eligibility criteria in real time. When a patient in a partner hospital system gets a new diagnosis, the AI cross-references their full medical history with thousands of active trials within 24 hours. Lucas walks through the specific technical challenge: unstructured clinical notes written in free text, which traditional keyword searches miss entirely. Luna flags the ethical tension — hospitals sharing data with a third-party AI — and the workaround using de-identified queries. They close on the economics: a single trial day costs drug companies an estimated $8 million in lost revenue, so even a modest speedup delivers billions in value.

#ClinicalTrials #AI #Triall #PatientMatching #NaturalLanguageProcessing #HealthTech #DigitalHealth #DrugDevelopment #ElectronicHealthRecords #TrialEnrollment #Pharmaceutical #Biotech #Business #Technology #FexingoBusiness #BusinessPodcast #LucasAndLuna #HealthAI

Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore how wearable devices and remote monitoring tools are reshaping clinical trial design. They focus on a specific case: the use of Apple Watch, Fitbit, and continuous glucose monitors by a mid-size biotech firm to reduce trial costs by 30% and improve patient retention. Lucas explains how the FDA's 2023 guidance on digital health technologies paved the way, and Luna questions whether the data is reliable enough for regulators. A concrete look at a quiet revolution in drug development.

#DigitalHealth #ClinicalTrials #Wearables #RemoteMonitoring #AppleWatch #Fitbit #ContinuousGlucoseMonitor #FDA #Biotech #Pharmaceuticals #DrugDevelopment #PatientRetention #HealthTech #RegulatoryScience #DecentralizedTrials #RealWorldEvidence #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna explore how artificial intelligence is transforming mental health therapy apps from generic chatbots into personalized treatment tools. They examine the case of Woebot Health, which uses cognitive behavioral therapy frameworks combined with large language models to deliver tailored interventions. The discussion covers how these apps analyze user input to adapt responses in real time, the challenges of maintaining therapeutic quality at scale, and the regulatory landscape, including FDA clearance for digital therapeutic devices. Specific numbers include Woebot's 2024 clinical trial showing 30% reduction in depression symptoms over 8 weeks. The hosts also touch on the ethical implications of AI in mental health, including data privacy and the risk of over-reliance on automated support. Listeners will gain a concrete understanding of the current state and future trajectory of AI-driven mental health tools.

#AITherapy #MentalHealthTech #DigitalTherapeutics #WoebotHealth #CognitiveBehavioralTherapy #LargeLanguageModels #PersonalizedCare #FDA #ClinicalTrials #DataPrivacy #Business #Technology #HealthTech #AIEthics #Startup #RemoteCare #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Pharmacies aren't just for picking up prescriptions anymore. CVS, Walgreens, and Rite Aid are remaking themselves as digital health hubs — offering telehealth visits, chronic disease monitoring via apps, and even wearable device sales. In this episode, Lucas and Luna dig into how the biggest retail pharmacy chains are using software and partnerships to capture a bigger share of the healthcare dollar. They focus on CVS's 2024 launch of a virtual primary care platform and the ripple effects on insurers and independent pharmacists. If you've ever wondered why your pharmacy seems to be pushing a health app at checkout, this episode explains the strategy behind it — and what it means for patient privacy and competition.

#CVS #Walgreens #RiteAid #Telehealth #DigitalHealth #Pharmacy #VirtualCare #HealthTech #RetailPharmacy #PrimaryCare #ChronicDisease #Wearables #HealthApps #Business #Technology #FexingoBusiness #BusinessPodcast #DigitalHealthPodcast

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna explore how retail pharmacy chains like CVS and Walgreens are transforming primary care through in-store clinics and virtual health services. They discuss the economics behind MinuteClinic and VillageMD, the impact on traditional doctor visits, and whether this model improves access or just shifts costs. With 10,000 retail clinic locations expected by 2027, they break down what this means for patients and the healthcare system.

#RetailClinics #PrimaryCare #CVS #Walgreens #MinuteClinic #VillageMD #Telehealth #HealthAccess #HealthcareCosts #BusinessModel #Disruption #DigitalHealth #Business #Technology #FexingoBusiness #BusinessPodcast #HealthcareInnovation #PatientCare

Keep every episode free: buymeacoffee.com/fexingo

Episode 60 of The Digital Health Podcast explores how mRNA technology is being repurposed from COVID-19 vaccines to create personalized cancer immunotherapies. Lucas and Luna break down the science behind neoantigen prediction, the case of Moderna and Merck's melanoma trial showing 44% reduction in recurrence risk, and the logistical hurdles of manufacturing a custom vaccine for each patient within weeks. They discuss how AI-powered tumor sequencing enables this precision, the cost implications (around $100,000 per course), and what this means for the future of oncology. A concrete look at how digital health and genomics are converging to make individualized cancer treatment a reality.

#mRNA #CancerVaccines #PersonalizedMedicine #Immunotherapy #Moderna #Merck #Melanoma #Neoantigen #TumorSequencing #AIHealth #DigitalHealth #Oncology #Biotech #Genomics #HealthcareAI #Business #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Antibiotic resistance is one of the most pressing global health threats, and digital health tools are emerging as a critical line of defense. In this episode, Lucas and Luna explore how AI-driven diagnostic platforms are helping clinicians prescribe antibiotics more precisely, reducing the spread of superbugs. They dive into a specific case: a machine learning algorithm developed at a UK hospital that predicts bacterial resistance patterns from routine lab data, cutting inappropriate antibiotic use by 30 percent. Along the way, they discuss the economics of deploying these tools in low-resource settings, the data-sharing challenges that slow adoption, and why this might be one of the highest-ROI applications of health AI. A rare intersection of public health urgency and smart business model design.

#AntibioticResistance #Superbugs #AIDiagnostics #DigitalHealth #MachineLearning #ClinicalDecisionSupport #HealthTech #InfectiousDisease #PrecisionMedicine #Microbiology #UKHealthTech #NHS #PublicHealth #HealthAI #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #PodcastEpisode

Keep every episode free: buymeacoffee.com/fexingo

In this episode, Lucas and Luna explore how smart inhalers are transforming asthma care by connecting patients and doctors with real-time data. They discuss how companies like Propeller Health and Teva are embedding sensors into inhalers to track medication usage, detect triggers, and reduce emergency visits. The hosts examine a clinical study showing a 50% reduction in asthma-related hospitalizations with smart inhaler use, and consider the challenges of cost, data privacy, and insurance coverage. They also touch on the broader implications for respiratory care and digital health adherence monitoring. Tune in for a focused look at a specific device category that's quietly improving outcomes for millions.

#SmartInhalers #AsthmaManagement #PropellerHealth #Teva #DigitalHealth #RespiratoryCare #WearableTech #HealthTech #AdherenceMonitoring #ClinicalStudy #HospitalizationReduction #RemoteMonitoring #HealthData #InsulinPumpAnalogy #BusinessAndTechnology #HealthcareInnovation #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo